Cali cancer registry methods
Fuente:
Redalyc
Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Universidad del Valle
2018
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1876471914992500736 |
|---|---|
| author | Luz Stella García |
| author_facet | Luz Stella García |
| contents | Cali cancer registry methods Luz Stella García Luis Eduardo Bravo Paola Collazos Oscar Ramírez Edwin Carrascal Marcela Nuñez Nelson Portilla Erquinovaldo Millan Medicina Cali methods Colombia Cancer registry data management Background: The Population Cancer Registry of Cali (RPCC) has operated since 1962, disseminating high quality information to provide a framework to assess and control the burden of cancer in Cali.Methods: The collection of new cancer cases in permanent residents of Cali is done through active search in and notification from hospitals, and public and private laboratories. The Secretary of Municipal Public Health provides individual information on general mortality and death from cancer. Tumors are coded with ICDO-3 and mortality with ICD-10. Presented rates are standardized by age and trends are assessed by estimating the percentage annual change using the regression analysis in JoinPoint. The 5-year net survival was analyzed with the Pohar-Perme estimator. Results: The 88.5% of the registered cancers had morphological verification (MV). The proportion of unknown primary site represented 5% and the death certificate only cases (DCO) varied between 0 to3% depending on the cancer site. All deaths were certified by a physician, 94.2% of cancer deaths were correctly certified. The ill-defined site proportion was 5.3% and that of uterine cancer not specified (C55) was 0.5%. For survival analysis, existing data collection procedure and infrastructure ensures assessment of the patient’s vital status and follow-up, with an average lost to follow-up of 13.2%.Comment: The information has been published in the eleven volumes of "Cancer Incidence in Five Continents" confirming high quality of the collected data. The RPCC PCRC has also participated in the Concord Study and is participating in SURVCAN-3. 2018 artículo científico 0120-8322 https://www.redalyc.org/articulo.oa?id=28355922014 https://www.redalyc.org/journal/283/28355922014/ https://www.redalyc.org/journal/283/28355922014/html/ https://www.redalyc.org/journal/283/28355922014/28355922014.epub https://www.redalyc.org/journal/283/28355922014/movil 10.25100/cm.v49i1.3853 en http://www.redalyc.org/revista.oa?id=283 Colombia Médica application/pdf Universidad del Valle Colombia Médica (Colombia) Num.1 Vol.49 |
| format | Artículo científico |
| id | redalyc_28355922014 |
| institution | Redalyc |
| language | en |
| publishDate | 2018 |
| publisher | Universidad del Valle |
| spellingShingle | Cali cancer registry methods Luz Stella García Medicina Cali methods Colombia Cancer registry data management Cali cancer registry methods Luz Stella García Luis Eduardo Bravo Paola Collazos Oscar Ramírez Edwin Carrascal Marcela Nuñez Nelson Portilla Erquinovaldo Millan Medicina Cali methods Colombia Cancer registry data management Background: The Population Cancer Registry of Cali (RPCC) has operated since 1962, disseminating high quality information to provide a framework to assess and control the burden of cancer in Cali.Methods: The collection of new cancer cases in permanent residents of Cali is done through active search in and notification from hospitals, and public and private laboratories. The Secretary of Municipal Public Health provides individual information on general mortality and death from cancer. Tumors are coded with ICDO-3 and mortality with ICD-10. Presented rates are standardized by age and trends are assessed by estimating the percentage annual change using the regression analysis in JoinPoint. The 5-year net survival was analyzed with the Pohar-Perme estimator. Results: The 88.5% of the registered cancers had morphological verification (MV). The proportion of unknown primary site represented 5% and the death certificate only cases (DCO) varied between 0 to3% depending on the cancer site. All deaths were certified by a physician, 94.2% of cancer deaths were correctly certified. The ill-defined site proportion was 5.3% and that of uterine cancer not specified (C55) was 0.5%. For survival analysis, existing data collection procedure and infrastructure ensures assessment of the patient’s vital status and follow-up, with an average lost to follow-up of 13.2%.Comment: The information has been published in the eleven volumes of "Cancer Incidence in Five Continents" confirming high quality of the collected data. The RPCC PCRC has also participated in the Concord Study and is participating in SURVCAN-3. 2018 artículo científico 0120-8322 https://www.redalyc.org/articulo.oa?id=28355922014 https://www.redalyc.org/journal/283/28355922014/ https://www.redalyc.org/journal/283/28355922014/html/ https://www.redalyc.org/journal/283/28355922014/28355922014.epub https://www.redalyc.org/journal/283/28355922014/movil 10.25100/cm.v49i1.3853 en http://www.redalyc.org/revista.oa?id=283 Colombia Médica application/pdf Universidad del Valle Colombia Médica (Colombia) Num.1 Vol.49 |
| title | Cali cancer registry methods |
| topic | Medicina Cali methods Colombia Cancer registry data management |
| url | https://www.redalyc.org/articulo.oa?id=28355922014 https://www.redalyc.org/journal/283/28355922014/ https://www.redalyc.org/journal/283/28355922014/html/ https://www.redalyc.org/journal/283/28355922014/28355922014.epub https://www.redalyc.org/journal/283/28355922014/movil |